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Abstract 
Purpose: To investigate in silico the drug-like properties of alkaloids (arecoline, arecaidine, guvacine, 
guvacoline, isoguvacine, arecolidine and homoarecoline) obtained from the fruits of Areca catechu L 
(areca nut). 
Methods: All chemical structures were re-drawn using Chemdraw Ultra 11.0. Furthermore, software 
including Bio-Loom for Windows - version 1.5, Molinspiration Property Calculator and ACD/I-LAB 
service were used to predict the drug-like properties of the alkaloids, including relative molecular mass 
(MW), partition coefficient log P (cLog P), number of hydrogen bond donors (HBD), number of hydrogen 
bond acceptors (HBA), topological polar surface area (TPSA), number of rotatable bonds (NROTB), 
pKa, and aqueous solubility at a given pH (LogS). In addition, Lipinski’s rule was used to evaluate drug-
like properties.    
Results: From our research, MWs of the seven compounds were all < 500. HBD and cLog P values of 
the seven compounds were all < 5, and HBA values were all < 10. In addition, TPSA value of each 
compound was < 60 Å2, and NROTB value was < 10. Besides, pKa values of the seven alkaloids were 
> 7.5; furthermore, they possess good solubility at pH 1.0, 5.0, and 7.0.  
Conclusion: All the seven alkaloids possess good drug-like properties, and demonstrated good oral 
absorption and bioavailability. The results also suggest that these compounds can be further developed 
into new oral drugs for treating certain diseases. 
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The fruit of Areca catechu L (areca nut), 
belonging to Arecaceae family, is an important 
folk medicine used in China to treat parasitic 
diseases, digestive disorders, and edema [1,2]. 
In addition, areca nut currently is one of the most 
important traditional Chinese medicines (TCM) in 
the Pharmacopoeia of the People’s Republic of 
China [3]. Modern pharmacological investigations 
have demonstrated that areca nut possesses 
several bioactivities including anti-parasitic effect 
[4], digestive effect [5,6], anti-depressive effect 
[7], anti-oxidant effect [8], anti-bacterial effect [9], 
anti-inflammatory and analgesic effects [10].  
 
Previous phytochemical studies reported that 
areca nut contains various chemical compounds 
that mainly include alkaloids [11] and tannins 
[12]. Moreover, alkaloids have been 
demonstrated as the main active constituents 
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responsible for the pharmacological actions of 
areca nut [2,13].  
 
Besides good pharmacological effects, ideal 
drugs should possess a good bioavailability 
profile including solubility, permeability, 
lipophilicity, pKa, and stability [14]. Drug-like 
properties researchers have mainly investigated 
the bioavailability profiles of candidate 
compounds [15]. To the best of our knowledge, 
there has been no investigation on the drug-like 
properties of alkaloids of areca nut, and this has 
limited the development of its constituents. 
Therefore, the objective of the present stud was 
to investigate the drug-like properties of alkaloids 
of areca nut (see Figure 1), namely, arecoline, 
arecaidine, guvacine, guvacoline, isoguvacine, 





Data sources for in silico assessment   
 
The seven pyridine-type alkaloids of Areca nut, 
viz, arecoline, arecaidine, guvacine, guvacoline, 
isoguvacine, arecolidine, homoarecoline, were 
assessed in the present investigation. All 
chemical structures of the seven compounds 
were re-drawn using Chemdraw Ultra 11.0 
(Cambridge Soft Corporation, MA, USA) and 
converted to MOL files before application to each 
assess software.  
 
In silico assessment software used and 
determination rules 
 
The Bio-Loom for windows version 1.5 (BioByte 
Corporation, CA, USA), Molinspiration Property 
Calculator [16], and ACD/I-LAB service 
(Advanced Chemistry Development, UK) were 
used to predict the drug-like parameters for the 
seven alkaloids. These parameters include 
relative molecular mass (MW), partition 
coefficient log P (cLog P), number of hydrogen 
bond donors (HBD), number of hydrogen bond 
acceptors (HBA), topological polar surface area 
(TPSA), number of rotatable bonds (NROTB), 
pKa, and aqueous solubility at a given pH 
(LogS). 
  
Lipinski’s rules were used to evaluate the drug-
like properties [17] while good absorption or 
permeation of candidate drugs were predicted 
globally according to the following criteria [17]: 
(1) Not more than 5 H-bond donors (nitrogen or 
oxygen atoms with one or more hydrogen 
atoms); (2) Not more than 10 H-bond acceptors 
(nitrogen or oxygen atoms); (3) A molecular 
weight (MW) under 500 (g/moL); (4) A partition 
coefficient log P (cLog P) < 5.  
 
In addition, a drug can be absorbed over 90 % if 
the TPSA value is < 60 Å2 [18]. The NROTB 
value of a candidate drug is also very important 
for its absorptive ability, and a good absorption 
might be predicted by a NROTB value < 10 [19]. 






                      Figure 1: Chemical structure of the alkaloids of areca nut 
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According to our present investigation, the in 
silico predictive results of drug-like properties of 
alkaloids from areca nut are shown in Table 1 
and Table 2. The MV of each of the seven 
compounds including arecoline, arecaidine, 
guvacine, guvacoline, isoguvacine, arecolidine 
and homoarecoline, was < 500. The number of 
hydrogen bond donors and cLog P values of the 
seven compounds was also < 5 while the 
number of hydrogen bond acceptors was < 10, 
TPSA values of the seven compounds were all 
less than 60 Å2, and NROTB were all < 10. 
These predicted results indicate that the seven 
alkaloids possess potential good oral absorption 
and that their absorptivity would be > 90 %.  
 
The pKa values of the arecoline, arecaidine, 
guvacine, guvacoline, isoguvacine, arecolidine, 
and homoarecoline were 7.84 ± 0.40, 8.44 ± 
0.20, 9.43 ± 0.20, 8.94 ± 0.40, 10.05 ± 0.20, and 
7.92 ± 0.40, respectively; thus, they are all > 7.5. 
Furthermore, the solubility of each of the seven 
alkaloids was also predicted in silico. However, 
the results revealed that only three alkaloids - 
arecoline, guvacoline and homoarecoline - 
exhibited good solubility at all the test pH of 1.0, 
5.0, and 7.0. 
DISCUSSION 
 
In our present investigation, we firstly studied the 
drug-like properties of the seven alkaloids from 
areca nut in silico, and found that the three 
alkaloids including arecoline, guvacoline and 
homoarecoline, were predicted to possess good 
drug-like properties, indicating that these 
alkaloids may possess good oral absorption and 
bioavailability. 
 
Nowadays, it is well known that an ideal 
candidate drug should possess some good 
characteristics of absorptive property and 
bioavailability besides pharmacological activity 
[20]. In addition, it is estimated that less than 2 in 
10000 candidate drugs are authorized for 
treatment of diseases, and computer-aided drug 
design (CADD) can be used to improve the 
current situation of drug development by using in 
silico assessment [16,17]. In recent drug screen 
strategy, the in silico, in vivo, and in vitro are 
commonly used together in the early high 
throughput screening (HTS) (Figure 2). The in 
silico results can be used to predict the in vivo 
and in vitro experiments, and can also predict the 
drug-like properties of the candidate drugs. 
 
 
             Table 1: Constitutive properties of the alkaloids of areca nut 
 








(≤140 Å2) a 
NROTB 
(≤10) a pKa 
Arecoline 155.19 0.90 0 3 29.50 2 7.84 ± 0.40 
Arecaidine 141.17 -1.75 1 3 40.50 1 8.44 ± 0.20 
Guvacine 127.14 -2.30 2 3 49.30 1 9.43 ± 0.20 
Guvacoline 141.16 0.49 1 3 38.30 2 8.94 ± 0.40 
Isoguvacine 127.14 -2.84 2 3 49.30 1 10.05 ± 0.20 
Arecolidine 155.19 1.11 0 3 21.70 2 4.24 ± 0.60 
Homoarecoline 169.22 1.43 0 3 29.50 3 7.92 ± 0.40 
acriteria filter for good oral absorption; b a drug with TPSA <60 Å2 will be completely absorbed, 
Fa > 90%. Note: MW = relative molecular mass; logD = the apparent logP values at a given 
pH; HBD = number of hydrogen bond donors; HBA = number of hydrogen bond acceptors; 
TPSA = topological polar surface area; NROTB = number of rotatable bonds; pKa = the 
values of the acid-base dissociation constant 




and solubility (g/L) 
LogS (pH5.0)c 
and solubility (g/L) 
LogS (pH 7.0)c 
and Solubility (g/L) 
Arecoline 0.81 (1000) 0.81 (1000) -0.42 (58.7) 
Arecaidine 0.85 (1000) -1.05 (12.6) -1.04 (12.9) 
Guvacine 0.90 (1000) 0.008 (12.5) -1.02 (12.1) 
Guvacoline 0.85 (1000) 0.85 (1000) 0.75 (800) 
Isoguvacine 0.90 (1000) -0.98 (13.4) -0.99 (12.9) 
Arecolidine 0.60 (615.2) -1.31 (7.62) -1.38 (6.52) 
Homoarecoline 0.77 (1000) 0.77 (1000) -0.79 (27.7) 
c LogS value in the biological pH range: pH 1.0 (stomach), pH 5.0 (duodenum) and pH 7.0 (jejunum); salivary pH 
varies between 5.5 and 7.0, depending on the flow rate. Note: LogS = aqueous solubility at a given pH (Log 
mol/L); solubility (g/L) 
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Figure 2: Relationship of the in vivo, in vitro, and in 
silico experiments 
 
Drug-like properties mainly include solubility, 
permeability, lipophilicity, pKa and stability. The 
solubility, permeability, lipophilicity, and TPSA 
are the main factors for bioavailability of oral 
drugs [21,22]. Currently, Lipinski’s rule is widely 
used in evaluating the drug-like properties of 
candidate drugs in database and guiding to 
screen orally bioavailable drugs [19]. Lipinski’s 
rules states that oral bio-availability of a drug is 
likely to exist if it possesses the following 
features: MW ≤ 500; H-bond donors ≤ 5; H-bond 
acceptors ≤ 10; c logP values ≤ 5. In the present 
study, our results in silico predicted that all the 
seven alkaloids of areca nut obeyed the 
Lipinski’s rules. In addition, our results 
demonstrated that the pKa values of the seven 
alkaloids were higher than 7.5, indicating that 
these compounds can exist in intestinal tract 
(pKa value were 7.3) in a non-ionic form. 
Solubility can directly affect the in vivo 
bioavailability of oral administered drugs, and a 
low solubility is the main reason for losing activity 
in vivo. According to the results of the present 
investigation, three alkaloids - arecoline, 
guvacoline and homoarecoline – possess good 
solubility at pH 1.0, 5.0, and 7.0, which indicates 
that these compounds can easily dissolve in 
stomach (approx. pH 1.0), duodenum (approx. 
pH 5.0), and jejunum (approx. pH 7.0). 
 
Therefore, based on based on all the parameters 
evaluated, three alkaloids of areca nut, namely, 
arecoline, guvacoline and homoarecoline 




Arecoline, guvacoline and homoarecoline 
possess good drug-like properties, and show 
good oral absorption and bioavailability. 
Therefore, these compounds can potentially be 
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